{"id":16551,"date":"2020-10-29T08:03:30","date_gmt":"2020-10-29T06:03:30","guid":{"rendered":"https:\/\/vilkaviskiovsb.lt\/?p=16551"},"modified":"2020-10-29T08:03:30","modified_gmt":"2020-10-29T06:03:30","slug":"vyriausybe-pritare-skirti-papildomu-lesu-vaistinio-preparato-remdesiviro-isigijimui","status":"publish","type":"post","link":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/2020\/10\/29\/vyriausybe-pritare-skirti-papildomu-lesu-vaistinio-preparato-remdesiviro-isigijimui\/","title":{"rendered":"Vyriausyb\u0117 pritar\u0117 skirti papildom\u0173 l\u0117\u0161\u0173 vaistinio preparato remdesiviro \u012fsigijimui"},"content":{"rendered":"<p><strong>Tre\u010diadien\u012f Vyriausyb\u0117s pos\u0117dyje pritarta Sveikatos apsaugos ministerijos (SAM) si\u016blymui skirti papildom\u0173 l\u0117\u0161\u0173 vaistinio preparato remdesiviro, skirto koronaviruso (COVID-19) sukeltai pneumonijai gydyti, \u012fsigijimui. I\u0161 viso vaistini\u0173 preparat\u0173 \u012fsigijimui iki \u0161i\u0173 met\u0173 pabaigos skirta 1 mln. 952 t\u016bkst. eur\u0173.<\/strong><\/p>\n<p>Lietuva dalyvauja Europos Komisijos (EK) vykdomuose bendruose pirkimuose, skirtuose \u012fsigyti vaistin\u012f preparat\u0105 remdesivir\u0105. \u0160iuo metu yra sudaryta sutartis su EK vykdyt\u0173 vie\u0161\u0173j\u0173 pirkim\u0173 proced\u016br\u0173 metu atrinktu vaisto gamintoju \u201eGilead Sciences Ireland UC\u201c. \u0160i sutartis u\u017etikrina remdesiviro tiekim\u0105 Lietuvai spalio-kovo m\u0117nesiams.<\/p>\n<p>\u012esigyjamas vaistinio preparato kiekis tur\u0117t\u0173 u\u017etikrinti Lietuvai \u012fsigyti reikalingus kiekius. Juos nustatant buvo atsi\u017evelgta \u012f gydymo \u012fstaig\u0173 pateikt\u0105 poreik\u012f, epidemiologines prognozes, specialist\u0173 pateikt\u0105 informacij\u0105 apie tik\u0117tinus sergan\u010di\u0173j\u0173 bei hospitalizuot\u0173 asmen\u0173 d\u0117l koronaviruso skai\u010dius.<\/p>\n<p>Ministerija primena, kad tam tikras kiekis vaistinio preparato remdesiviro Lietuvai buvo pristatytas pagal kit\u0105 EK administruojam\u0105\u00a0 instrument\u0105 ESI (Europos S\u0105jungos (ES) skubios paramos priemon\u0117, skirta pad\u0117ti ES valstyb\u0117ms krizini\u0173 situacij\u0173 atvejais), kuomet vaistin\u012f preparat\u0105 \u012fsigijusi EK pagal tam tikr\u0105 metodik\u0105, atsi\u017evelgiant \u012f epidemiologin\u0119 situacij\u0105, padalino poreik\u012f i\u0161rei\u0161kusioms valstyb\u0117ms nar\u0117ms. Gautas vaistinis preparatas buvo paskirstytas penkioms pagrindin\u0117ms u\u017e kov\u0105 su koronavirusu atsakingoms gydymo \u012fstaigoms ir LSMU Kauno klinikoms. Min\u0117tose gydymo \u012fstaigose \u0161is vaistinis preparatas yra naudojamas sergan\u010di\u0173j\u0173 koronavirusu ir turin\u010di\u0173 pneumonij\u0105 gydymui.<\/p>\n<p><em><a href=\"https:\/\/sam.lrv.lt\/lt\/kontaktai-ziniasklaidai\" target=\"_blank\" rel=\"noopener noreferrer\">SAM Spaudos tarnyba<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Tre\u010diadien\u012f Vyriausyb\u0117s pos\u0117dyje pritarta Sveikatos apsaugos ministerijos (SAM) si\u016blymui skirti papildom\u0173 l\u0117\u0161\u0173 vaistinio preparato remdesiviro, skirto koronaviruso (COVID-19) sukeltai pneumonijai gydyti, \u012fsigijimui. I\u0161 viso vaistini\u0173 preparat\u0173 \u012fsigijimui iki \u0161i\u0173 met\u0173 pabaigos skirta 1 mln. 952 t\u016bkst. eur\u0173. Lietuva dalyvauja Europos Komisijos (EK) vykdomuose bendruose pirkimuose, skirtuose \u012fsigyti vaistin\u012f preparat\u0105 remdesivir\u0105. \u0160iuo metu yra sudaryta sutartis&hellip;<\/p>\n","protected":false},"author":3,"featured_media":16552,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[6],"tags":[],"class_list":["post-16551","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-naujienos","category-6","description-off"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7kWFe-4iX","jetpack_featured_media_url":"https:\/\/vilkaviskiovsb.lt\/wp-content\/uploads\/2020\/10\/18000_ea821e08ac150c18d8692353e4b2a007.jpg","post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/16551","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/comments?post=16551"}],"version-history":[{"count":1,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/16551\/revisions"}],"predecessor-version":[{"id":16553,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/16551\/revisions\/16553"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/media\/16552"}],"wp:attachment":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/media?parent=16551"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/categories?post=16551"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/tags?post=16551"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}